ArticleiScience2026
Streamlined CRISPR-based assays for detection and subtyping of H5 and H7 avian influenza.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
Avian influenza viruses (AIVs) are zoonotic pathogens that pose an increasing global threat due to their potential for significant economic losses in agriculture, and the risk of a pandemic should human-to-human transmission occur. In light of this, we need rapid, sensitive, and specific tests to detect and differentiate circulating AIVs. Current AIV diagnostic methods require specialized laboratory equipment, limiting their use in the field and in low-resource settings. Here, we develop three CRISPR-based Streamlined Highlighting of Infections to Navigate Epidemics (SHINE) assays that address these limitations. We designed, optimized, and validated a SHINE assay for H5 AIV, achieving 100% specificity when tested on seasonal-influenza-positive clinical samples, and a limit of detection of 121.7 copies/μL. We also developed SHINE assays targeting the 2.3.4.4b A(H5N1) and Eurasian H7 lineages. Together, these SHINE assays offer a promising platform for AIV diagnosis and surveillance, particularly outside laboratory settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.